Literature DB >> 19638252

Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adults.

Karsten Müssig1, Thomas Leyhe, Britta Besemer, Ralf Saur, Hans-Ulrich Häring, Baptist Gallwitz, Stefan Klingberg.   

Abstract

Pituitary adenomas, even after successful treatment, are associated with cognitive dysfunctions. We hypothesized that an association between the age of the patients at pituitary surgery and neuropsychological outcome may exist. Forty-two patients (mean age 51 +/- 10 years) who had been successfully treated for pituitary adenoma (surgery with or without subsequent radiotherapy) underwent neuropsychological testing. Age at treatment (mean 37 +/- 11 years) was significantly associated with Trail Making Test, Part B (TMT-B) results, a measure of executive control and attention (r = .60, p < .0001). This association remained significant after adjustment for age at testing and time since treatment (r = .42, p = .008). No associations were detected between age at treatment and Trail Making Test, Part A (TMT-A, attentional speed), the digit span test (acoustic working memory), and the German version of the Auditory Verbal Learning and Memory, and Memory Test (verbal memory, all p > or = .3). Our data suggest a favorable effect of younger age at treatment in adults on neurocognitive outcome after surgery for pituitary adenoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19638252     DOI: 10.1017/S1355617709990324

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  2 in total

1.  Evidence of dysexecutive syndrome in patients with acromegaly.

Authors:  Shaobo Shan; Lingling Fang; Jia Huang; Raymond C K Chan; Guijun Jia; Weiqing Wan
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

2.  Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma.

Authors:  Wen Lyu; Xu Fei; Cheng Chen; Yuqun Tang
Journal:  Gland Surg       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.